81327 Sept9 gen prmtr mthyltn alys
Also known as: SEPT9 methylation test, colorectal cancer screening
Septin 9 (SEPT9) gene promoter methylation analysis for colorectal cancer screening and detection.
In Plain Language
Colon cancer blood test; Colorectal cancer screening marker
Clinical Context
Detects SEPT9 promoter methylation in blood as a noninvasive biomarker for colorectal cancer screening and detection.
RVU Information
CPT 81327 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81327?
CPT 81327 (Sept9 gen prmtr mthyltn alys) is a Pathology & Lab code. Septin 9 (SEPT9) gene promoter methylation analysis for colorectal cancer screening and detection.
Who uses CPT code 81327?
CPT 81327 is used by Pathology, Oncology, Gastroenterology. Detects SEPT9 promoter methylation in blood as a noninvasive biomarker for colorectal cancer screening and detection.
When is CPT 81327 used?
Detects SEPT9 promoter methylation in blood as a noninvasive biomarker for colorectal cancer screening and detection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.